Join +750K new investors every month who copy stock picks from billionaire's portfoliosSign Up Free

Syphilis cases in US newborns rise 10-fold over a decade

Published 11/07/2023, 01:05 PM
Updated 11/08/2023, 01:15 AM

By Sriparna Roy

(Reuters) -The number of newborns with syphilis in the United States surged more than 10-fold in the last decade, the U.S. Centers for Disease Control and Prevention (CDC) reported on Tuesday.

The agency said 3,761 cases were recorded in 2022, the highest in over 30 years, up from 334 cases in 2012. The 2022 cases included 231 stillbirths and 51 infant deaths.

Nine out of 10 cases might have been prevented with timely testing and treatment during pregnancy, said Laura Bachmann, chief medical officer in CDC's Division of STD Prevention.

Syphilis is a sexually transmitted infection that can cause serious health problems without treatment, and during pregnancy, can lead to stillbirth, miscarriage, infant death, and maternal and infant morbidity.

By treating patients quickly, healthcare professionals could reduce some of the greatest hurdles to the care some mothers need, said Bachmann.

Congenital syphilis occurs when a mother with syphilis passes the infection to her baby during pregnancy.

© Reuters. FILE PHOTO: A mother holds her baby in Fort Worth, Texas, U.S., April 10, 2020. REUTERS/Callaghan O'Hare/File Photo

The CDC recommends screening for syphilis at the first prenatal care visit to reduce perinatal transmission.

Benzathine penicillin G is the only recommended treatment for syphilis during pregnancy that must be administered as a single-dose injection or three doses spaced seven to nine days apart, depending on the stage of infection, according to the CDC.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.